Picture of Rohto Pharmaceutical logo

4527 — Rohto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Rohto -2018/19 parent results

May 10 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            104.38           96.88                                
                 (+7.7 pct)      (+8.2 pct)                              
  Operating         13.01           12.86                                
                 (+1.2 pct)      (+20.3 pct)                             
  Recurring         15.19           14.84                                
                 (+2.3 pct)      (+15.8 pct)                             
  Net                4.82            7.63                                
                 (-36.9 pct)     (+2.6 pct)                              
  EPS             42.26 yen       67.01 yen                              
  EPS Diluted     42.10 yen       66.73 yen                              
  Ann Div         25.00 yen       22.00 yen      26.00 yen               
  -Q2 Div         11.00 yen       11.00 yen      13.00 yen               
  -Q4 Div         14.00 yen       11.00 yen      13.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T

Recent news on Rohto Pharmaceutical

See all news